Cedars Sinai Medical Center - Net Worth and Insider Trading

Cedars Sinai Medical Center Net Worth

The estimated net worth of Cedars Sinai Medical Center is at least $2 Million dollars as of 2024-04-25. Cedars Sinai Medical Center is the 10% Owner of Capricor Therapeutics Inc and owns about 404,996 shares of Capricor Therapeutics Inc (CAPR) stock worth over $2 Million. Details can be seen in Cedars Sinai Medical Center's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cedars Sinai Medical Center has not made any transactions after 2017-05-09 and currently still holds the listed stock(s).

Transaction Summary of Cedars Sinai Medical Center

To

Cedars Sinai Medical Center Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cedars Sinai Medical Center owns 2 companies in total, including Capricor Therapeutics Inc () , and Prometheus Biosciences Inc () .

Click here to see the complete history of Cedars Sinai Medical Center’s form 4 insider trades.

Insider Ownership Summary of Cedars Sinai Medical Center

Ticker Comapny Transaction Date Type of Owner
Capricor Therapeutics Inc 2017-05-09 10 percent owner
Prometheus Biosciences Inc 2021-03-11 10 percent owner

Cedars Sinai Medical Center Latest Holdings Summary

Cedars Sinai Medical Center currently owns a total of 1 stock. Cedars Sinai Medical Center owns 404,996 shares of Capricor Therapeutics Inc (CAPR) as of May 9, 2017, with a value of $2 Million.

Latest Holdings of Cedars Sinai Medical Center

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAPR Capricor Therapeutics Inc 2017-05-09 404,996 5.15 2,085,729

Holding Weightings of Cedars Sinai Medical Center


Cedars Sinai Medical Center Form 4 Trading Tracker

According to the SEC Form 4 filings, Cedars Sinai Medical Center has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 114,516 shares on May 9, 2017, which cost Cedars Sinai Medical Center around $4 Million.

Insider Trading History of Cedars Sinai Medical Center

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cedars Sinai Medical Center Trading Performance

GuruFocus tracks the stock performance after each of Cedars Sinai Medical Center's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cedars Sinai Medical Center is 0.16%. GuruFocus also compares Cedars Sinai Medical Center's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cedars Sinai Medical Center within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cedars Sinai Medical Center's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cedars Sinai Medical Center

Average Return

-22.7%

Average return per transaction

Outperforming Transactions

33%

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.78 0.16 1.98 -22.7 -40.64 -44.84
Relative Return to S&P 500(%) -19.81 -3.32 -5.26 -37.91 -54.75 -54.85

Cedars Sinai Medical Center Ownership Network

Ownership Network List of Cedars Sinai Medical Center

No Data

Ownership Network Relation of Cedars Sinai Medical Center


Cedars Sinai Medical Center Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Cedars Sinai Medical Center is the 10 percent owner of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .

Capricor Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Cedars Sinai Medical Center made no insider transaction in Capricor Therapeutics Inc (). Other recent insider transactions involving Capricor Therapeutics Inc () include a net purchase of 7,993 shares made by David B Musket , a net sale of 17,772 shares made by Xavier Avat , and a net purchase of 10,000 shares made by Collier Earl M Jr .

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,772 shares of Capricor Therapeutics Inc () were sold and 22,993 shares were bought by its insiders, resulting in a net purchase of 5,221 shares.

Capricor Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Capricor Therapeutics Inc Insider Transactions

No Available Data

Cedars Sinai Medical Center Mailing Address

Above is the net worth, insider trading, and ownership report for Cedars Sinai Medical Center. You might contact Cedars Sinai Medical Center via mailing address: 8700 Beverly Blvd, Los Angeles Ca 90048-1865.

Discussions on Cedars Sinai Medical Center

No discussions yet.